Evidence map›Paper›PMID 28522897›Full record

ReviewMediators of inflammation2017

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.

Gilles Duvoisin, Robert N Lopez, Andrew S Day, Daniel A Lemberg, Richard B Gearry, Steven T Leach

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Mediators of inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021
    Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gilles DuvoisinDepartment of Paediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Robert N LopezDepartment of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, Australia.
Andrew S DayDepartment of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.ORCID 0000-0003-2290-7386
Daniel A LembergDepartment of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, Australia.ORCID 0000-0002-8583-0956
Richard B GearryDepartment of Paediatrics, University of Otago, Christchurch, Christchurch, New Zealand.
Steven T LeachSchool of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0001-9704-1666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility. This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.

Indexed as

AnimalsBiomarkersHumansInflammationInflammatory Bowel DiseasesBiomarkers

Identifiers

PMID28522897
PMCPMC5410373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.